Loading...
See More
Health

Novartis profits from emerging markets

Oct 28 2014 13:36

Swiss pharmaceutical group Novartis has reported that its net profit has risen in the third quarter, on the back of growing business in emerging economies.

Health

Ascendis Health makes yet another acquisition

Oct 27 2014 16:13

Ascendis Health has agreed to acquire the majority of The Scientific Group, comprising its diagnostics business, in a structured cash and shares deal.

Health

EU aids €200m to help develop Ebola vaccines

Oct 23 2014 10:45

Europe is to earmark €200m into the development of Ebola vaccines, as well as drugs and diagnostic tests, according to reliable sources.

Health

About 3 000 patients to recieve new TB drug

Oct 20 2014 20:12

A new drug will be made available to people who suffer from multidrug-resistant tuberculosis, a pharmaceutical company says.

Health

WHO backs higher tobacco taxes

Oct 15 2014 17:45

The World Health Organisation has approved guidelines on Wednesday urging countries to increase cigarette taxes to help discourage smoking.

News

Software issue casts doubt over some drugs

Oct 13 2014 19:54

The reliability of clinical tests used to win approval for some medicines could be in doubt due to an apparent software glitch.

Health

US approves pricey new pill against hepatitis C

Oct 12 2014 16:45

US regulators have approved a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments, but that carries a steep price tag.

Health

Aspen, GSK team up to extend foothold in Japan

Oct 09 2014 13:24

South Africa's Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline to extend its foothold in Japan, a lucrative market for low-cost medicines.

Economy

'Animal pharm' catches Wall Street's attention

Oct 08 2014 21:07

Cancer drugs for cats, pain relief for dogs, diarrhoea drugs for hogs and hormones for dairy cattle: animal health is rapidly attracting Wall Street investors.

Health

UK cost agency rejects GW's cannabis drug

Oct 08 2014 11:32

A pioneering cannabis drug developed by British firm GW Pharmaceuticals for treating spasticity in multiple sclerosis has been rejected as not cost-effective.

Inside Fin24.com

 
Health

EU clears Novartis plan to sell animal health

Oct 03 2014 14:00

EU regulators have cleared the proposed sale of the animal health business of Swiss pharmaceutical giant Novartis to US group Eli Lilly.

Health

Deal between Sanlam and AfroCentric

Sep 30 2014 17:35

Afrocentric Investment Corporation and Sanlam have reached agreements for the issue to Sanlam of an interest in AfroCentric’s wholly-owned subsidiary.

We're talking about:

Small Business

Retailers of any shape and size can now unlock the power of mobile transacting.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

e.tv boss Marcel Golding's suspension as HCI chairperson should be:

Previous results · Suggest a vote

Loading...